Synthesis  	Synthesis  	 NNP	O
and  	and  	 CC	O
molecular  	molecular  	 JJ	B-NP
modelling  	modelling  	 JJ	I-NP
studies  	studies  	 NNS	I-NP
of  	of  	 IN	O
8-arylpyrido 	8-arylpyrido 	 NNP	O
[ 	[ 	 -LRB-	O
3 	3 	 NNP	O
' 	' 	 POS	O
, 	, 	 ,	O
2 	2 	 CD	O
' 	' 	 ''	O
: 	: 	 :	O
4,5 	4,5 	 CD	O
] 	] 	 -RRB-	O
thieno 	thieno 	 NNS	B-NP
[ 	[ 	 -LRB-	O
3,2-d 	3,2-d 	 NNP	O
] 	] 	 -RRB-	O
pyrimidin-4-amines  	pyrimidin-4-amines  	 CD	B-NP
as  	as  	 IN	O
multitarget  	multitarget  	 FW	B-NP
Ser 	Ser 	 FW	I-NP
/ 	/ 	 FW	I-NP
Thr  	Thr  	 FW	I-NP
kinases  	kinases  	 FW	I-NP
inhibitors  	inhibitors  	 FW	O
This  	This  	 DT	O
paper  	paper  	 NN	O
reports  	reports  	 VBZ	O
the  	the  	 DT	O
design  	design  	 NN	O
and  	and  	 CC	O
synthesis  	synthesis  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
novel  	novel  	 NN	O
series  	series  	 NN	O
of  	of  	 IN	O
8-arylpyrido 	8-arylpyrido 	 NNP	O
[ 	[ 	 -LRB-	O
3 	3 	 NNP	O
' 	' 	 POS	O
, 	, 	 ,	O
2 	2 	 CD	O
' 	' 	 ''	O
: 	: 	 :	O
4,5 	4,5 	 CD	O
] 	] 	 -RRB-	O
thieno 	thieno 	 NNS	B-NP
[ 	[ 	 -LRB-	O
3,2-d 	3,2-d 	 NNP	O
] 	] 	 -RRB-	O
pyrimidin-4-amines  	pyrimidin-4-amines  	 CD	B-NP
via  	via  	 IN	O
microwave-assisted  	microwave-assisted  	 JJ	O
multi-step  	multi-step  	 JJ	B-NP
synthesis 	synthesis 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
common  	common  	 JJ	O
precursor  	precursor  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
whole  	whole  	 JJ	O
series 	series 	 NN	O
,  	,  	 ,	O
3-amino-5-bromothieno 	3-amino-5-bromothieno 	 NNP	O
[ 	[ 	 -LRB-	O
2,3-b 	2,3-b 	 NNP	O
] 	] 	 -RRB-	O
pyridine-2-carbonitrile 	pyridine-2-carbonitrile 	 NNP	B-NP
,  	,  	 ,	O
was  	was  	 VBD	O
rapidly  	rapidly  	 RB	O
synthesized  	synthesized  	 VBN	O
in  	in  	 IN	O
one  	one  	 CD	O
step  	step  	 NN	O
from  	from  	 IN	O
commercially-available  	commercially-available  	 JJ	O
5-bromo-2-chloronicotinonitrile 	5-bromo-2-chloronicotinonitrile 	 NN	O
.  	.  	 .	O
Formylation  	Formylation  	 NNP	B-NP
with  	with  	 IN	O
DMF-DMA  	DMF-DMA  	 NNP	B-NP
led  	led  	 VBD	O
to  	to  	 TO	O
( 	( 	 -LRB-	B-NP
E 	E 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
-N 	-N 	 JJ	I-NP
' 	' 	 ''	I-NP
- 	- 	 :	I-NP
( 	( 	 -LRB-	I-NP
5-bromo-2-cyanothieno 	5-bromo-2-cyanothieno 	 NNP	I-NP
[ 	[ 	 -LRB-	I-NP
2,3-b 	2,3-b 	 NNP	I-NP
] 	] 	 -RRB-	O
pyridin-3-yl 	pyridin-3-yl 	 CD	B-NP
) 	) 	 -RRB-	I-NP
-N 	-N 	 NNP	I-NP
, 	, 	 ,	O
N-dimethylformimidamide  	N-dimethylformimidamide  	 NNP	B-NP
( 	( 	 -LRB-	O
4 	4 	 LS	O
)  	)  	 -RRB-	O
which  	which  	 WDT	O
was  	was  	 VBD	O
conveniently  	conveniently  	 RB	O
functionalized  	functionalized  	 VBN	O
at  	at  	 IN	O
position  	position  	 NN	O
8  	8  	 CD	O
by  	by  	 IN	O
palladium-catalyzed  	palladium-catalyzed  	 JJ	B-NP
Suzuki-Miyaura  	Suzuki-Miyaura  	 JJ	I-NP
cross-coupling  	cross-coupling  	 JJ	I-NP
to  	to  	 TO	O
introduce  	introduce  	 VB	O
a  	a  	 DT	O
heteroaromatic  	heteroaromatic  	 JJ	B-NP
ring 	ring 	 NN	I-NP
.  	.  	 .	O
High-temperature  	High-temperature  	 JJ	B-NP
formamide-mediated  	formamide-mediated  	 JJ	I-NP
cyclization  	cyclization  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
cyanoamidine  	cyanoamidine  	 FW	I-NP
intermediate  	intermediate  	 FW	I-NP
gave  	gave  	 FW	O
seventeen  	seventeen  	 FW	O
8-arylpyrido 	8-arylpyrido 	 FW	O
[ 	[ 	 -LRB-	O
3 	3 	 NNP	O
' 	' 	 POS	O
, 	, 	 ,	O
2 	2 	 CD	O
' 	' 	 ''	O
: 	: 	 :	O
4,5 	4,5 	 CD	O
] 	] 	 -RRB-	O
thieno 	thieno 	 NNS	B-NP
[ 	[ 	 -LRB-	O
3,2-d 	3,2-d 	 NNP	O
] 	] 	 -RRB-	O
pyrimidin-4-amines 	pyrimidin-4-amines 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
potency  	potency  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
final  	final  	 JJ	I-NP
products  	products  	 NNS	I-NP
was  	was  	 VBD	O
evaluated  	evaluated  	 VBN	O
against  	against  	 IN	O
five  	five  	 CD	O
protein  	protein  	 NN	B-NP
kinases  	kinases  	 NNS	I-NP
( 	( 	 -LRB-	O
CDK5 	CDK5 	 NNP	B-NP
/ 	/ 	 NNP	O
p25 	p25 	 NNP	B-NP
,  	,  	 ,	O
CK1δ 	CK1δ 	 CD	B-NP
/ 	/ 	 CD	O
ε 	ε 	 NN	O
,  	,  	 ,	O
GSK3α 	GSK3α 	 CD	B-NP
/ 	/ 	 CD	O
β 	β 	 NN	O
,  	,  	 ,	O
DYRK1A  	DYRK1A  	 NNP	O
and  	and  	 CC	O
CLK1 	CLK1 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
revealed  	revealed  	 VBD	O
that  	that  	 IN	O
8- 	8- 	 NNP	O
( 	( 	 -LRB-	O
2,4-dichlorophenyl 	2,4-dichlorophenyl 	 NNP	O
) 	) 	 -RRB-	O
pyrido 	pyrido 	 NNS	O
[ 	[ 	 -LRB-	O
3 	3 	 NNP	O
' 	' 	 POS	O
, 	, 	 ,	O
2 	2 	 CD	O
' 	' 	 ''	O
: 	: 	 :	O
4,5 	4,5 	 CD	O
] 	] 	 -RRB-	O
thieno 	thieno 	 NNS	B-NP
[ 	[ 	 -LRB-	O
3,2-d 	3,2-d 	 NNP	O
] 	] 	 -RRB-	O
pyrimidin-4-amine  	pyrimidin-4-amine  	 FW	O
1g  	1g  	 FW	O
specifically  	specifically  	 FW	O
inhibits  	inhibits  	 FW	O
CK1δ 	CK1δ 	 FW	B-NP
/ 	/ 	 FW	O
ε  	ε  	 FW	O
and  	and  	 CC	O
CLK1  	CLK1  	 NNP	B-NP
( 	( 	 -LRB-	O
220  	220  	 CD	O
and  	and  	 CC	O
88 nM 	88 nM 	 NNP	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
)  	)  	 -RRB-	O
while  	while  	 IN	O
its  	its  	 PRP$	O
7- 	7- 	 NNP	O
( 	( 	 -LRB-	O
2,4-dichlorophenyl 	2,4-dichlorophenyl 	 NNP	O
) 	) 	 -RRB-	O
pyrido 	pyrido 	 NNS	O
[ 	[ 	 -LRB-	O
3 	3 	 NNP	O
' 	' 	 POS	O
, 	, 	 ,	O
2 	2 	 CD	O
' 	' 	 ''	O
: 	: 	 :	O
4,5 	4,5 	 CD	O
] 	] 	 -RRB-	O
thieno 	thieno 	 NNS	B-NP
[ 	[ 	 -LRB-	O
3,2-d 	3,2-d 	 NNP	O
] 	] 	 -RRB-	O
pyrimidin-4-amine  	pyrimidin-4-amine  	 CD	B-NP
isomer  	isomer  	 CD	I-NP
10  	10  	 CD	O
showed  	showed  	 VBD	O
no  	no  	 DT	O
activity  	activity  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
panel  	panel  	 NN	O
of  	of  	 IN	O
tested  	tested  	 JJ	O
kinases 	kinases 	 NN	B-NP
.  	.  	 .	O
Molecular  	Molecular  	 JJ	B-NP
modelling  	modelling  	 NN	I-NP
of  	of  	 IN	O
10  	10  	 CD	O
and  	and  	 CC	O
1g  	1g  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
ATP  	ATP  	 NNP	B-NP
binding  	binding  	 JJ	O
sites  	sites  	 NNS	O
of  	of  	 IN	O
CK1δ 	CK1δ 	 CD	B-NP
/ 	/ 	 CD	O
ε  	ε  	 NNS	O
and  	and  	 CC	O
CLK1  	CLK1  	 NNP	B-NP
showed  	showed  	 VBD	O
that  	that  	 DT	O
functionalization  	functionalization  	 NN	B-NP
at  	at  	 IN	O
position  	position  	 NN	O
7  	7  	 CD	O
of  	of  	 IN	O
pyrido 	pyrido 	 NNS	B-NP
[ 	[ 	 -LRB-	O
3 	3 	 NNP	O
' 	' 	 POS	O
, 	, 	 ,	O
2 	2 	 CD	O
' 	' 	 ''	O
: 	: 	 :	O
4,5 	4,5 	 CD	O
] 	] 	 -RRB-	O
thieno 	thieno 	 NNS	B-NP
[ 	[ 	 -LRB-	O
3,2-d 	3,2-d 	 NNP	O
] 	] 	 -RRB-	O
pyrimidin-4-amines  	pyrimidin-4-amines  	 NNP	B-NP
is  	is  	 VBZ	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
induce  	induce  	 VB	O
a  	a  	 DT	O
steric  	steric  	 JJ	B-NP
clash  	clash  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
CK1δ 	CK1δ 	 CD	B-NP
/ 	/ 	 CD	O
ε  	ε  	 CD	O
P-loop  	P-loop  	 JJ	O
and  	and  	 CC	O
thus  	thus  	 RB	O
a  	a  	 DT	O
complete  	complete  	 JJ	O
loss  	loss  	 NN	O
of  	of  	 IN	O
inhibitory  	inhibitory  	 JJ	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
